Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

METTLER TOLEDO INTERNATIONAL INC/ (MTD)

CIK 0001037646 2 material events

Insider activity (SEC Form 4)

Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.

Open-market · last 30 days: 0 buyers bought $0 1 seller sold $1.3M
Open-market · last 90 days: 0 buyers bought $0 4 sellers sold $6.1M
InsiderRoleDateTransactionSharesValue
SHUMAN-FABBRI NATALIA Director 2026-08-28 Grant/award 16 $0
Kaltenbach Patrick President and CEO 2026-08-27 Option exercise 942 $965K
Kaltenbach Patrick President and CEO 2026-08-27 Open-market sell 942 $1.3M
SALICE THOMAS P Director 2026-08-05 Option exercise 417 $166K
SALICE THOMAS P Director 2026-08-05 Open-market sell 417 $601K
Keller Gerry Head of Process Analytics 2026-08-03 Option exercise 240 $173K
Keller Gerry Head of Process Analytics 2026-08-03 Open-market sell 240 $343K
SALICE THOMAS P Director 2026-08-03 Option exercise 415 $165K
SALICE THOMAS P Director 2026-08-03 Open-market sell 415 $600K
Vadala Shawn Chief Financial Officer 2026-08-03 Option exercise 2240 $1.3M
Vadala Shawn Chief Financial Officer 2026-08-03 Open-market sell 2240 $3.2M
Graham-Bryce Susan Chief Human Resources Officer 2026-05-12 Grant/award 71 $0
Kaltenbach Patrick President and CEO 2026-05-12 Grant/award 810 $0
Keller Gerry Head of Process Analytics 2026-05-12 Grant/award 100 $0
Vadala Shawn Chief Financial Officer 2026-05-12 Grant/award 291 $0
Wittorf Oliver Head of PI, Retail, and GSC 2026-05-12 Grant/award 87 $0
Wong Ann Ping Richard Head of Asia & Pacific 2026-05-12 Grant/award 103 $0
TOKICH MICHAEL J Director 2026-02-17 Grant/award 50 $0
Vadala Shawn Chief Financial Officer 2026-02-10 Option exercise 800 $476K
Vadala Shawn Chief Financial Officer 2026-02-10 Open-market sell 800 $1.1M
Most recent 20 reported transactions. Open-market buys (P) and sells (S) are the deliberate ones; grants and option exercises are compensation. Not investment advice.

Risk Radar (year-over-year Risk Factors)

← All Risk Radar

Fiscal period ending 2025-12-31 versus 2024-12-31view filing on EDGAR →

Tariff costs crystallized at $50M incremental in 2025, leverage rose meaningfully with debt up $200M to $2.2B and credit facility utilization climbing, and Eurozone macro exposure widened on multiple fronts — together representing a real, broad-based deterioration in the risk profile. The shift from hypothetical to realized cost impacts across tariffs and OECD minimum tax removes prior optionality and locks in a higher cost base. Tightening liquidity headroom alongside rising leverage is the most actionable near-term concern for credit and counterparty monitors.

1 company-specific · 2 common-mode

Company-specific changes

Revised

Debt increased from $2.0B to $2.2B; credit facility borrowings rose from $734.7M to $813.7M, reducing available liquidity and increasing leverage risk materially.

Risks Related to Our Debt We have debt and we may incur substantially more debt, which could affect our financial position and may otherwise restrict our activities. We have debt and we may incur…

Also disclosed — common-mode (Tariffs trade policy, Geopolitical macro uncertainty)
Tariffs trade policy Revised

Tariffs shifted from hypothetical to realized: $50M incremental cost in 2025. OECD minimum tax changed from "proposed" to "adopted." Concrete financial impact disclosed.

Legal, Tax, Regulatory, and Other Risks Unanticipated changes in our tax rates or additional income tax liabilities could impact our profitability. We are subject to income taxes in the United States…

Geopolitical macro uncertainty Revised

Eurozone risk escalated: new specific triggers (rising interest rates, defense spending, slow growth) and currency exposure increased from $39M to $53.7M on 5% USD weakening.

Table of Contents Strategic Risks A prolonged downturn or additional consolidation in the pharma/biopharmaceutical, food manufacturing, and chemical industries could adversely affect our operating…

Material year-over-year changes to this company's Risk Factors (Item 1A), found by comparing each annual report to the prior year, judged for materiality, and classified as company-specific or common-mode against the cross-company catalog. Common-mode changes are the macro themes many companies disclose in common; they are collapsed above. A filing marked unchanged had no material change from the prior year; its summary describes the company's standing risks, which remain in force. Fiscal periods are the reporting period ends. Not investment advice.

Exec appointment

8-K filed 2026-08-03 confidence 95% Item 5.02

Mettler-Toledo appointed Natalia Shuman as a director effective August 3, 2026, with the Board determining she qualifies as independent under NYSE listing standards. The Board also resolved to increase its size from nine to ten directors in connection with this appointment. Shuman brings extensive executive experience including CEO roles at MISTRAS Group and Bureau Veritas North America.

View raw filing on EDGAR →

Earnings release

8-K filed 2026-07-30 confidence 98% Item 2.02

This Item 2.02 disclosure reports Mettler-Toledo's financial results for the three and six months ended June 30, 2026, with a press release attached as Exhibit 99.1. The filing presents GAAP and non-GAAP results including net sales, earnings per share (reported EPS of $11.55 vs. prior-year $9.76 for Q2; $19.87 vs. $17.56 for six months), and forward guidance for Q3 and full-year 2026. This is a standard quarterly earnings release disclosure material to investors assessing the company's operational and financial performance.

View raw filing on EDGAR →